Cognition Therapeutics
Price & Volume
Stats
See more52W Range | $0.34-$2.95 |
Market Cap | $31.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.96 |
News
See moreYahoo Finance • last year
Cognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantitative EEG Experts, Drs Willem de Haan and Philip Scheltens
Yahoo Finance • last year
Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer’s and Parkinson’s Diseases
Yahoo Finance • last year
Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease
Yahoo Finance • last year
Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
About
CEO | Ms. Lisa Ricciardi |
Address | 2500 Westchester Ave., Purchase, NY, United States, 10577 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
